Monotherapy

Monotherapy - most related articles:

- Tykerb with Herceptin increases advanced breast cancer survival - 3.3
- Risperdal Consta approved for bipolar disorder - 3.1
- Drugs for epilepsy increases fracture risk in older - 3.1
- Victoza, liraglutide approved for type 2 diabetes - 2.7
- Artemisinin based anti malarial drugs becoming resistant to malaria - 2.3
- UCB's Cimzia approved for rheumatoid arthritis adults - 2.2

Monotherapy articles

Risperdal Consta approved for bipolar disorder
Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the Supplemental New Drug Applications (sNDAs) for the use of RISPERDAL® CONSTA® (risperidone) Long-Acting Treatment as both monotherapy and adjunctive therapy to lithium or valproate in the maintenance treatment of Bipolar I Disorder.

1 Monotherapy articles listed above.


Mission
Health Newstrack is dedicated to serve recent and updated health & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
1.07